Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

I was somewhat disappointed by the articles inherent bias towards the US. There is no reason why the US should place its strong IP laws and history of pharmaceutical innovation in jeopardy during the opening salvos of an international treaty negotiations.


This brings up an interesting question. what is the BATNA of these countries. That is, what is their recourse if nobody can agree?




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: